Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "ctDNA Dynamics & Survival Outcomes in Pts with aNSCLC and High (>50%) PD-L1 Expression Randomized to Cemiplimab vs. Chemo"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Natalie Vokes
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Natalie Vokes
147 views
June 21, 2023
Comments 0
Login to view comments.
Click here to Login
Lung